Skip to main content
Kiniksa Pharmaceuticals International, plc (KNSA)
NASDAQ: KNSA · Real-Time Price · USD
46.16
+0.14 (0.30%)
Mar 6, 2026, 4:00 PM EST - Market closed

KNSA Revenue by Segment
Period Ending Dec 31, 2025Sep 30, 2025Jun 30, 2025Mar 31, 2025Dec 31, 2024Sep 30, 2024Jun 30, 2024Mar 31, 2024Dec 31, 2023Sep 30, 2023Jun 30, 2023Mar 31, 2023Dec 31, 2022Sep 30, 2022Jun 30, 2022Mar 31, 2022
Product
677.56M 597.97M 529.33M 475.93M 417.03M 365.71M 318.30M 269.40M
Product Growth
62.47% 63.51% 66.30% 76.66% 78.85% 81.14% 86.67% 88.40%
License and Collaboration
- - - - - - 20.63M 32.37M 37.08M 46.85M 110.32M 103.34M - - - -
License and Collaboration Growth
- - - - - - -81.30% -68.68% - - - - - - - -
Source: Business metrics provided by Main Street Data and sourced from official company press releases and documents.